Luiza Reali Nazario
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
JAN KORNELIS DE COCK-STICHTING Foundation
Open Date:
Close Date:
Articles (7)
Year:
2026
Year:
2026
Year:
2026
Year:
2024
Introduction Bacterial infections are a major problem in medicine, and the rapid and accurate detection of such infections is essential for optimal patient outcome. Bacterial infections can be diagnosed by nuclear imaging, but most currently available modalities are unable to discriminate infection from sterile inflammation. Bacteria-targeted positron emission tomography (PET) tracers have the potential to overcome this hurdle. In the present study, we compared three 18 F-labelled PET tracers based on the clinically applied antibiotic vancomycin for targeted imaging of Gram-positive bacteria. Methods [ 18 F]FB-NHS and [ 18 F]BODIPY-FL-NHS were conjugated to vancomycin. The resulting conjugates, together with our previously developed [ 18 F]PQ-VE1-vancomycin, were tested for stability, lipophilicity, selective binding to Gram-positive bacteria, antimicrobial activity and biodistribution. For the first time, the pharmacokinetic properties of all three tracers were compared in healthy animals to identify potential binding sites. Results [ 18 F]FB-vancomycin, [ 18 F]BODIPY-FL-vancomycin, and [ 18 F]PQ-VE1-vancomycin were successfully synthesized with radiochemical yields of 11.7%, 2.6%, and 0.8%, respectively. [ 18 F]FB-vancomycin exhibited poor in vitro and in vivo stability and, accordingly, no bacterial binding. In contrast, [ 18 F]BODIPY-FL-vancomycin and [ 18 F]PQ-VE1-vancomycin showed strong and specific binding to Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), which was outcompeted by unlabeled vancomycin only at concentrations exceeding clinically relevant vancomycin blood levels. Biodistribution showed renal clearance of [ 18 F]PQ-VE1-vancomycin and [ 18 F]BODIPY-FL-vancomycin with low non-specific accumulation in muscles, fat and bones. Conclusion Here we present the synthesis and first evaluation of the vancomycin-based PET tracers [ 18 F]BODIPY-FL-vancomycin and [ 18 F]PQ-VE1-vancomycin for image-guided detection of Gram-positive bacteria. Our study paves the way towards real-time bacteria-targeted diagnosis of soft tissue and implant-associated infections that are oftentimes caused by Gram-positive bacteria, even after prophylactic treatment with vancomycin.
Year:
2024
Year:
2024
Year:
2024
Collaborators (6)
Janine Doorduin
University Medical Center Groningen
Marco Demaria
Scientific Staff
University Medical Center Groningen
Robert P Coppes
Scientific Staff
Universitair Medisch Centrum Utrecht
Lara Barazzuol
Associate Professor
University Medical Center Groningen
Erik de Vries
full professor
Universitair Medisch Centrum Utrecht
Nadja Simeth
Associate Professor
University of Göttingen
Make your next move.
Prepare your application
Review drafts before you send them.